| CAM | | Documentation of all pharmacotherapies received by the patient. |
| Drug | | Medication is administered as required by the patient's condition. |
| Food and Drug Administration (FDA) | | As soon as possible order that should be available for administration to the patient within 30 minutes of the written order. |
| Pharmacology | | Study of how the body responds to drugs. |
| Pharmacotherapy | | Mechanism whereby drugs are absorbed across the intestinal wall and enter into the hepatic portal circulation. |
| Therapeutics | | Ability of a drug to reach the bloodstream and its target tissues. |
| Bioavailability | | General term for any substance capable of producing biologic responses in the body. |
| Chemical name | | The branch of medicine concerned with the treatment of disease and suffering. |
| Generic name | | Drug that is capable of binding with receptors to induce a cellular response. |
| Mechanism of action | | The study of medicines; the discipline pertaining to how drugs improve or maintain health. |
| Prototype drug | | Acquired hyperresponse of body defenses to a foreign substance (allergen). |
| Trade name | | The way in which a drug exerts its effects. |
| Allergic reaction | | Order written in advance of a situation that is to be carried out under specific circumstances. |
| Anaphylaxis | | The taking of multiple drugs concurrently. |
| ASAP order | | Dispensation of medications via a needle into the skin layers. |
| Buccal route | | Any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care provider, patient, or consumer. |
| Enteral route | | Proprietary name of a drug assigned by the manufacturer; also called the brand name or product name. |
| Enteric coated | | Treatments considered outside the realm of conventional Western medicine |
| Intradermal (ID) | | Total of all biochemical reactions in the body. |
| Parenteral route | | The process of removing substances from the body. |
| PRN order | | Administration of a tablet or capsule by placing it in the oral cavity between the gum and the cheek. |
| Standing order | | Medication administered into the dermis layer of the skin. |
| STAT order | | The process of transporting drugs through the body. |
| Subcutaneous | | Strict chemical nomenclature used for naming drugs established by the International Union of Pure and Applied Chemistry (IUPAC). |
| Sublingual route | | Medication delivered beneath the skin. |
| Absorption | | The length of time required for the plasma concentration of a drug to decrease by half after administration. |
| Distribution | | Referring to tablets that have a hard, waxy coating designed to dissolve in the alkaline environment of the small intestine. |
| Excretion | | Well-understood model drug |
| First-pass effect | | The ability of a drug to produce a desired response. |
| Metabolism | | U.S. agency responsible for the evaluation and approval of new drugs. |
| Pharmacokinetics | | Study of how drugs are handled by the body. |
| Plasma half-life (t 1/2) | | Drug that blocks the response of another drug. |
| Agonist | | Treatment or prevention of disease by means of drugs. |
| Antagonist | | Nonproprietary name of a drug assigned by the government. |
| Efficacy | | Acute allergic response to an antigen that results in severe hypotension and may lead to life-threatening shock if untreated. |
| Pharmacodynamics | | Administration of drugs orally, and through nasogastric or gastrostomy tubes. |
| Polypharmacy | | Administration of medication by placing it under the tongue and allowing it to dissolve slowly. |
| Medication administration record (MAR) | | Any medication that is needed immediately and is to be given only once. |
| Medication error | | The process of moving a drug across body membranes. |